144 related articles for article (PubMed ID: 37769200)
1. Gender differences in patient experience in idiopathic inflammatory myopathies: Sub analysis from the COVAD dataset.
Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Mod Rheumatol; 2023 Sep; ():. PubMed ID: 37769200
[TBL] [Abstract][Full Text] [Related]
2. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
Grignaschi S; Kim M; Zanframundo G; Ravichandran N; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Cavagna L; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2023 Sep; 43(9):1637-1649. PubMed ID: 37314497
[TBL] [Abstract][Full Text] [Related]
3. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2023 Mar; 62(3):1204-1215. PubMed ID: 35920795
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Doskaliuk B; Ravichandran N; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatol Int; 2023 Sep; 43(9):1651-1664. PubMed ID: 37351634
[TBL] [Abstract][Full Text] [Related]
6. Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study.
Shinjo SK; Kim M; Hoff LS; Missé RG; Sen P; Naveen R; Day J; Cordeiro RA; Júnior JG; Chatterjee T; Lilleker JB; Agarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Makol A; Tan AL; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Int J Rheum Dis; 2023 Apr; 26(4):727-739. PubMed ID: 36872076
[TBL] [Abstract][Full Text] [Related]
7. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
Sen P; R N; Houshmand N; Moghadam Kia S; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; ; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Oct; 62(10):3291-3301. PubMed ID: 36734536
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
Hoff LS; Ravichandran N; Shinjo SK; Day J; Sen P; Junior JG; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Milchert M; Makol A; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Cansu DÜ; Traboco L; Wibowo SAK; Tehozol EAZ; Serrano JR; La Torre IG; Wincup C; Pauling JD; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2023 Jan; 43(1):47-58. PubMed ID: 36271958
[TBL] [Abstract][Full Text] [Related]
9. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N; Sen P; Griger Z; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Jan; 63(1):127-139. PubMed ID: 37084267
[TBL] [Abstract][Full Text] [Related]
10. Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
Ziade N; Aoude M; Hmamouchi I; R N; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Knitza J; Kuwana M; Nune A; Cavagna L; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 Mar; 63(3):657-664. PubMed ID: 37228012
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables.
Valladales-Restrepo LF; Delgado-Araujo AC; Aristizábal-Carmona BS; Saldarriaga-Rivera LM; Machado-Alba JE
Int J Rheumatol; 2022; 2022():1807571. PubMed ID: 35845104
[TBL] [Abstract][Full Text] [Related]
12. Correlation of muscle ultrasound with clinical and pathological findings in idiopathic inflammatory myopathies.
Yoshida T; Yamazaki H; Nishimori Y; Takamatsu N; Fukushima K; Osaki Y; Taniguchi Y; Nozaki T; Kumon Y; Albayda J; Nishino I; Izumi Y
Muscle Nerve; 2023 Jul; 68(1):39-47. PubMed ID: 37118940
[TBL] [Abstract][Full Text] [Related]
13. In-patient comorbidities in inclusion body myositis: a United States national in-patient sample-based study.
Ma AK; Dai F; Roy B
Clin Exp Rheumatol; 2023 Mar; 41(2):261-266. PubMed ID: 36377563
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.
Zhen C; Hou Y; Zhao B; Ma X; Dai T; Yan C
Front Immunol; 2022; 13():1051609. PubMed ID: 36578492
[TBL] [Abstract][Full Text] [Related]
15. Temporomandibular Disorders and Oral Features in Idiopathic Inflammatory Myopathies (IIMs) Patients: An Observational Study.
Crincoli V; Cannavale M; Cazzolla AP; Dioguardi M; Piancino MG; Di Comite M
Int J Med Sci; 2021; 18(14):3158-3170. PubMed ID: 34400886
[No Abstract] [Full Text] [Related]
16. Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy.
Keret S; Saygin D; Moghadam-Kia S; Ren D; Oddis CV; Aggarwal R
Rheumatology (Oxford); 2023 Dec; 62(12):3957-3961. PubMed ID: 37348555
[TBL] [Abstract][Full Text] [Related]
17. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria.
Challa S; Jakati S; Uppin MS; Kannan MA; Liza R; Murthy Jagarlapudi MK
Neurol India; 2018; 66(3):767-771. PubMed ID: 29766941
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
20. Possible future avenues for myositis therapeutics: DM, IMNM and IBM.
Connolly CM; Plomp L; Paik JJ; Allenbach Y
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
